Gotham Asset Management’s AstraZeneca AZN Stock Holding History

Gotham Asset Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$381K	Sell	2,007 -861	-30%	-$162K	﹤0.01%	1580
2026 Q1	$566K	Buy	2,868 +783	+38%	+$151K	﹤0.01%	1461
2025 Q4	$383K	Buy	2,085 +716	+52%	+$126K	﹤0.01%	1504
2025 Q3	$210K	Buy	+1,369	New	+$207K	﹤0.01%	1606
2014 Q2	–	Sell	-95,518	Closed	-$6.2M	–	990
2014 Q1	$6.2M	Buy	+95,518	New	+$6.17M	0.09%	324

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Gotham Asset Management's AZN Position: Q2 2026 in Review

Gotham Asset Management reduced its AstraZeneca (AZN) stake by 30% in Q2 2026, selling an estimated $162K and leaving 2,007 shares worth $381K. The position accounts for ﹤0.01% of the portfolio, ranked #1580.

Gotham Asset Management first reported a position in AZN in Q1 2014 and has held it in 5 quarters since. The position peaked at $6.2M in Q1 2014. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Gotham Asset Management held 2,007 shares of AstraZeneca worth $381K as of Q2 2026.
Gotham Asset Management sold 861 AstraZeneca shares in Q2 2026, an estimated $162K.
AstraZeneca made up ﹤0.01% of Gotham Asset Management's portfolio in Q2 2026, its #1580 holding.
Gotham Asset Management first reported a position in AstraZeneca in Q1 2014 and has held it in 5 quarters since.
Gotham Asset Management's AstraZeneca position peaked at $6.2M in Q1 2014.
1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Gotham Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.